Mint balance
Mint sensory direction; 20-pouch tin. Single-extract ashwagandha assessment, including plant part and extract specification. Final ingredients and strengths remain subject to feasibility and market review.
Adaptogen Stress pouches
A botanical development path that starts with extract identity and market eligibility, before combining multiple adaptogen ingredients.
Your development starting point
A botanical development path that starts with extract identity and market eligibility, before combining multiple adaptogen ingredients.
Ingredient direction
Ashwagandha + rhodiola; magnolia bark as a separate review option
Flavor flexibility
Mint, berry, citrus, peach or a restrained neutral sensory study.
Pack flexibility
16- or 20-pouch tins and an individual barrier-pack assessment.
Project support
OEM, ODM, CRO and CDMO scopes can be quoted for this concept.
Specifications to agree
| Decision | Development position |
|---|---|
| Ingredient amount | Not fixed. Determine ingredient form, daily intake, safety and market eligibility before a dose is selected. |
| Fill weight | Set after payload and sensory feasibility; ingredient amount and total pouch mass are different. |
| Pouch dimensions | Proposed common direction: 2 × 3 cm; maximum proposed direction: 2 × 4 cm. |
| Pack count | 16 or 20 pouches per tin; individual moisture-barrier sachets can be assessed. |
| Onset and duration | Not established for this concept. No fixed or fast-acting effect is promised. |
| Shelf life | Assigned only after a stability program supports the formula and final packaging. |
| MOQ and lead time | Quoted per project, ingredient supply, pack format, testing and SKU count. |
| Development targets | Nicotine-free scope; sugar-free / plant-based options subject to composition review. |
Two formula review routes
Baseline assessment
Single-extract ashwagandha assessment, including plant part and extract specification.
Extended assessment
A rhodiola combination or a separately reviewed magnolia bark direction; a multi-extract formula is not an automatic extension of the base.
Botanical identity, marker compounds, extract solvent, supplier records and interaction warnings require careful review. Ashwagandha is not suitable for everyone; a botanical origin does not establish safety.
Six configurable briefs
Berry direction
Berry sensory direction; 16-pouch tin. Single-extract ashwagandha assessment, including plant part and extract specification. Final ingredients and strengths remain subject to feasibility and market review.
Citrus profile
Citrus sensory direction; 20-pouch tin. Single-extract ashwagandha assessment, including plant part and extract specification. Final ingredients and strengths remain subject to feasibility and market review.
Peach profile
Peach sensory direction; 16-pouch tin. A rhodiola combination or a separately reviewed magnolia bark direction; a multi-extract formula is not an automatic extension of the base. Final ingredients and strengths remain subject to feasibility and market review.
Botanical simplicity
Restrained botanical sensory direction; individual barrier sachet. A rhodiola combination or a separately reviewed magnolia bark direction; a multi-extract formula is not an automatic extension of the base. Final ingredients and strengths remain subject to feasibility and market review.
Neutral sensory study
Low-aroma sensory direction; tin + barrier-pack study. A rhodiola combination or a separately reviewed magnolia bark direction; a multi-extract formula is not an automatic extension of the base. Final ingredients and strengths remain subject to feasibility and market review.
Market and evidence review
For US projects, review the product category, ingredient eligibility, label and intended claims with the responsible importer and qualified adviser. For EU projects, check each destination country, ingredient status and permitted claims. Australia and New Zealand require separate classification and ingredient review; a decision for one market does not cover the other.
No public concept page confirms a product authorization or a manufacturing certificate. Ask for the applicable manufacturer records and the evidence needed for the finished specification. Generic ingredient literature does not establish buccal or sublingual absorption, onset or efficacy of this pouch.
Concept questions
Is Adaptogen Stress a finished product?
No. It is a configurable development direction. The six briefs help define a sample request, while formula, amounts, warnings, manufacturing scope and destination-market eligibility remain subject to review.
Can this direction be produced under my brand?
OEM, ODM, CRO and CDMO project scopes are available for assessment. The exact responsibilities, sampling costs, commercial terms, intellectual property and release criteria are agreed before work begins.
What claims can I use?
Botanical identity, marker compounds, extract solvent, supplier records and interaction warnings require careful review. Ashwagandha is not suitable for everyone; a botanical origin does not establish safety. Claims need a separate legal and evidence review for the intended market.
Can I order a sample?
Use the concept form below or the sample enquiry page. Sample scope, fees, shipping and the test plan are agreed first; an enquiry is not an order or payment.
Request this concept
Tell us your destination market, ingredient direction and packaging needs. The team can then assess the scope, sampling route and documentation to quote.